These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 2820687)

  • 21. Human parvovirus B19 infection in patients with chronic hepatitis B or hepatitis C infection.
    Hsu TC; Chen TY; Lin MC; Tzang BS; Tsay GJ
    J Gastroenterol Hepatol; 2005 May; 20(5):733-8. PubMed ID: 15853987
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serological study of parvovirus B19 infection in women with recurrent spontaneous abortions.
    Kishore J; Gupta I
    Indian J Pathol Microbiol; 2006 Oct; 49(4):548-50. PubMed ID: 17183849
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Parvovirus B19 infection in Chile: markers of infection and immunity in patients with clinical symptoms.
    Larrañaga C; León O; Díaz P; Miranda M; Norambuena X; Pérez M; Gaggero A
    J Med Virol; 2007 Dec; 79(12):1927-34. PubMed ID: 17935173
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Prevalence of anti-human parvovirus antibody in pregnant women].
    Yaegashi N; Okamura K; Hamazaki Y; Yajima A; Shiraishi H; Sugamura K
    Nihon Sanka Fujinka Gakkai Zasshi; 1990 Feb; 42(2):162-6. PubMed ID: 2179428
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Diagnostic of parvovirus B19 infection.
    Schwarz TF; Roggendorf M
    Behring Inst Mitt; 1990 Aug; (85):35-8. PubMed ID: 2171483
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Seroprevalence of antibodies to parvovirus B19 among children in Papua New Guinea.
    Wildig J; Mueller I; Kiniboro B; Maraga S; Siba P; Cossart Y
    Am J Trop Med Hyg; 2007 Aug; 77(2):354-7. PubMed ID: 17690412
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Comparative study of indirect immunofluorescence (IIF) and ELISA techniques in the detection of parvovirus B19].
    González M; Hassanhi M; Rivera S; Bracho MP
    Invest Clin; 2000 Mar; 41(1):19-27. PubMed ID: 10758696
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Seroprevalence of erythrovirus B19 IgG antibody among paediatric patients in Makkah and Jeddah, Kingdom of Saudi Arabia.
    Johargy A
    Med Princ Pract; 2009; 18(4):339-41. PubMed ID: 19494546
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of transfusion on human erythrovirus B19-susceptible or -infected pediatric recipients in a genotype 3-endemic area.
    Parsyan A; Addo-Yobo E; Owusu-Ofori S; Akpene H; Sarkodie F; Allain JP
    Transfusion; 2006 Sep; 46(9):1593-600. PubMed ID: 16965589
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of the Roche LightCycler parvovirus B19 quantification kit for the diagnosis of parvovirus B19 infections.
    Braham S; Gandhi J; Beard S; Cohen B
    J Clin Virol; 2004 Sep; 31(1):5-10. PubMed ID: 15288606
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Association of non-immunologically-induced hydrops fetalis with Parvovirus B19 infection].
    Schwarz TF; Roggendorf M; Simader R
    Geburtshilfe Frauenheilkd; 1987 Aug; 47(8):572-3. PubMed ID: 2820831
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evidence for persistence of human parvovirus B19 DNA in bone marrow.
    Cassinotti P; Burtonboy G; Fopp M; Siegl G
    J Med Virol; 1997 Nov; 53(3):229-32. PubMed ID: 9365887
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Seroprevalence of parvovirus B19 IgG in children affected by juvenile idiopathic arthritis.
    Weissbrich B; Süss-Fröhlich Y; Girschick HJ
    Arthritis Res Ther; 2007; 9(4):R82. PubMed ID: 17760961
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Parvovirus B19 infection in patients with congenital blood coagulation disorders].
    Aguilar Franco C; Lucía Cuesta JF; Ferrer Torres J; Omeñaca Teres M
    Med Clin (Barc); 1997 May; 108(17):641-6. PubMed ID: 9312580
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Chronic fatigue syndrome and arthralgia following parvovirus B19 infection.
    Kerr JR; Bracewell J; Laing I; Mattey DL; Bernstein RM; Bruce IN; Tyrrell DA
    J Rheumatol; 2002 Mar; 29(3):595-602. PubMed ID: 11911112
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Human parvovirus B19: ELISA and immunoblot assays.
    Schwarz TF; Roggendorf M; Deinhardt F
    J Virol Methods; 1988 Jun; 20(2):155-68. PubMed ID: 2843558
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Seroprevalence of parvovirus B19 in the German population.
    Röhrer C; Gärtner B; Sauerbrei A; Böhm S; Hottenträger B; Raab U; Thierfelder W; Wutzler P; Modrow S
    Epidemiol Infect; 2008 Nov; 136(11):1564-75. PubMed ID: 18198003
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Seroprevalence of human parvovirus B19 infection in Sao Tomé and Principe, Malawi and Mascarene Islands.
    Schwarz TF; Gürtler LG; Zoulek G; Deinhardt F; Roggendorf M
    Zentralbl Bakteriol; 1989 Jul; 271(2):231-6. PubMed ID: 2550018
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Human parvovirus B19 infections in United Kingdom 1984-86.
    Lancet; 1987 Mar; 1(8535):738-9. PubMed ID: 2882143
    [No Abstract]   [Full Text] [Related]  

  • 40. The prevalence of antibody to human parvovirus B19 in England and Wales.
    Cohen BJ; Buckley MM
    J Med Microbiol; 1988 Feb; 25(2):151-3. PubMed ID: 3339634
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.